Stocks and Investing
Stocks and Investing
Mon, January 22, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gil Blum Maintained (AUTL) at Strong Buy with Increased Target to $8 on, Jan 22nd, 2024
Gil Blum of Needham, Maintained "Autolus Therapeutics plc" (AUTL) at Strong Buy with Increased Target from $7 to $8 on, Jan 22nd, 2024.
Gil has made no other calls on AUTL in the last 4 months.
There is 1 other peer that has a rating on AUTL. Out of the 1 peers that are also analyzing AUTL, 0 agree with Gil's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gil
- James Shin of "Deutsche Bank" Initiated at Strong Buy and Held Target at $10 on, Thursday, November 9th, 2023
Contributing Sources